OCREVUS INFUSIONLUK SOLUTION HAZIRLAMAK ICIN KONSANTRE
300 mg/10ml 1x10ml
|Generic Name (Ingredient)||
Each vial contains okrelizumab solution at a concentration of 30 mg / mL. In total, each vial contains 300 mg of okrelizumab in 10 mL. The concentration of the drug obtained after dilution is about 1.2 mg / mL. Okrelizumab is a recombinant humanized anti-CD20 monoclonal antibody produced in Chinese Hamster Ovary cell lines by recombinant DNA technology.